Join Insilico Medicine for our exclusive Pharma AI Q3 Fall Update, where we will continue to showcase the acceleration of Pharma.ai’s leading platforms.

Gathering Pharma Executives, Computational Chemists, Biologics Researchers, and Translational Scientists, this interactive session explores the latest upgrades across the Pharma.ai suite. Discover how our self-directed AI agents, physics-based chemistry engines, and multi-omics target discovery tools are accelerating early discovery and improving clinical probability of success.

Newly Announced: We will unveil Insilico’s newest launches from Pharmaceutical Superintelligence (PSI) AI, to the O3DC Consortium, and the Drug Discovery and Development Benchmarks.